SOURCE: Kenergy Scientific, Inc.

July 14, 2011 12:15 ET

Kenergy Scientific, Inc. (PINKSHEETS: KNSC) Healthcare Patent Application Filed

FLEMINGTON, NJ--(Marketwire - Jul 14, 2011) - Ken Glynn, President and CEO of GreenSmart Stores and Kenergy Scientific, Inc. (PINKSHEETS: KNSC), today reported that a healthcare patent application was filed on July 12, 2011 by the company. Dr. Alain Martin and Ken Glynn are co-inventors of the novel biodegradable bandages with algae based artificial skin and healing accelerators, such as sodium pyruvate. The invention is jointly owned by Kenergy Scientific, Inc. and North Cell Pharmaceutical, Inc., with Kenergy owning 67% interest. Dr. Martin is the inventor of the antibacterial enhanced Neosporin and the enhanced Listerine formulas, and he is the CEO of North Cell Pharmaceutical, Inc.

Another invention being developed jointly by Ken Glynn and Dr. Alain Martin involves medication for reducing risk of death from lung pulmonary embolisms for patients who have clots or high risk of clotting. This will be another cooperative effort between Kenergy Scientific, Inc. and North Cell Pharmaceutical, Inc.

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements are based on the current plans and expectations of management and are subject to a number of uncertainties and risks that could significantly affect the company's current plans and expectations, as well as future results of operations and financial condition. A more extensive listing of risks and factors that may affect the company's business prospects and cause actual results to differ materially from those described in the forward-looking statements can be found in the reports and other documents filed by the company with the Securities and Exchange Commission. The company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

Contact Information

  • Contact:
    Kenergy Scientific, Inc.
    Ken Glynn
    CEO and President
    908 788 0077